Long view on China

Fidelity Growth Partners Asiathinks longer can be better in Chinese investments, and expects a single LP, global reach and an established presence will allow it to take an extended approach with a new China fund that's targeting $250 million.

About half of the fund will go to China-based healthcare companies, with the remainder split between consumer and IT plays. Within healthcare, there will be investments in pharmaceutical, drug development, biologics, device, consumables and services companies...